Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in:  Forbes

Forbes reporter covering science and medicine

A Question For Sanofi: What About Genzyme?

forbes.com — One thing that has not been mentioned with regard to Sanofi's ouster of CEO Chris Viehbacher: Although he has resigned his directorship and been removed as chief executive, there has been no mention of what happens to Viehbacher's position as chairman of the board at Genzyme, Sanofi's Cambridge, Mass.-based biotech outpost [...]

Dear Sanofi: Firing CEO Chris Viehbacher Is A Huge Mistake

forbes.com — One of the world's largest drug companies just fired its boss over a bad quarter, a worse relationship with the board, and the company's own wrong-headed resistance to change. It looks like a huge mistake. Christopher Viehbacher was brought in to run Sanofi (then known as Sanofi-Aventis) in September 2008.

Sarepta Needs FDA Expertise, Stat

forbes.com — Chris Garabedian, the chief executive of Cambridge, Mass.-based Sarepta Therapeutics, just seems to be in over his head. Sarepta, which is developing a series of promising treatments for Duchenne muscular dystrophy, is a company Garabedian has built around a risky proposition: that the U.S. Food and Drug Administration will approve its [...]

A Defense Of The Ebola Quarantine

forbes.com — When Andrew Cuomo and Chris Christie, the governors of New York and New Jersey, announced that they would be putting in place an enforced quarantine when medical workers who had contact with Ebola in Liberia, Sierra Leone, or Guinea enter the United States, my immediate reaction was that this was [...]

Why You Won't Catch Ebola On The New York City Subway

forbes.com — Ebola has come to New York City, as a heroic physician who was treating patients in Guinea with Médecins Sans Frontières has tested positive for the disease. The doctor, identified in press reports as Craig Spencer, is a reminder that even some of the most stringent protocols for creating barriers against the [...]

Could High Drug Prices Be Bad For Innovation?

forbes.com — Policymakers are scrutinizing high prices for specialty drugs like never before. Gilead's Sovaldi at $84,000 for a treatment course is in part to blame -- or credit -- for this, but so are Vertex' Kalydeco, Merck's Keytruda , and a series of other six figure drugs. The pharmaceutical industry has responded [...]

The CDC Told Hospital Workers They Could Travel After Being Exposed To Ebola

forbes.com — In trying to figure out the time line of what exactly the Centers for Disease Control & Prevention told health care workers exposed to Ebola in Dallas about traveling, I've learned that none of those nurses, doctors, or other workers were initially told to avoid planes, buses, or other forms [...]

Why Americans Still Shouldn't Be Scared Of Catching Ebola

forbes.com — The utter failure of state and federal authorizes to protect two nurses who treated a Liberian Ebola patient in Texas make it seem that America's defenses against this deadly virus have crumbled. That the Centers for Disease Control & Prevention may have told one of those nurses she could get [...]

Ebola Outbreak Shows The Dark Side Of Mother Nature

forbes.com — It was an amber August night in Western Uganda in 2007. As the director of the U.S. Centers for Disease Control and Prevention (CDC), I suited up in full biosafety gear to observe a team of our top disease detectives as they tried to find the source of a deadly [...]

The Serious Problem With Obama's Ebola Czar Choice

forbes.com — Both CNBC and CNN are reporting that the White House has named Ron Klain, a former chief of staff for Vice Presidents Gore and Biden, as the point man who will coordinate the administration's response to the threat of Ebola patients showing up in the U.S. At first blush, Klain [...]
More Articles →
Oct 31, 2014

@DShaywitz @ReformedBroker It's been a great week for being reminded not to trust biotech CEOs.

Oct 31, 2014

RT @JohnCFierce: Fierce life sciences will end Oct with 1.3M web visits, an avg 122,000 daily readers, 275K subscribers. That's a new record. Great team.

Oct 31, 2014

RT @ReformedBroker: That thing where a banker’s wife says she did cocaine / group sex with a CEO client and you own the stock. $AEGR pic.twitter.com/11E1lttxBY

Oct 31, 2014

@jeffbercovici @adamfeuerstein We will now debate whether J. Crew meets the definition of "hipster pants."

Oct 31, 2014

RT @MikeNGladstone: @matthewherper @adamfeuerstein definitely. $AEGR also banked on uptake into "phenotypically" HoFH pts who are actually hets. Not happening

Oct 31, 2014

RT @aaronecarroll: .@aaronecarroll Some tell me that it's only twice as likely with newer data. Fine. Kids are still hit by cars tonight more than any other.

Learn how to connect with Matthew on social media by joining Muck Rack Pro



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


Share This Profile